Elena Feinstein
Directeur Technique/Scientifique/R&D chez Quark Pharmaceuticals, Inc.
Postes actifs de Elena Feinstein
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Directeur Technique/Scientifique/R&D | 01/01/1998 | - |
Historique de carrière de Elena Feinstein
Formation de Elena Feinstein
| Moscow University | Doctorate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 2 |
| Russie | 2 |
| Israël | 2 |
Opérationnelle
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Bourse
- Insiders
- Elena Feinstein
- Expérience
